Terms: = Thyroid cancer AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
13 results:
1. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
[TBL] [Abstract] [Full Text] [Related]
2. Impact of COVID-19 on the thyroid gland: an update.
Scappaticcio L; Pitoia F; Esposito K; Piccardo A; Trimboli P
Rev Endocr Metab Disord; 2021 Dec; 22(4):803-815. PubMed ID: 33241508
[TBL] [Abstract] [Full Text] [Related]
3. An investigation into the molecular basis of cancer comorbidities in coronavirus infection.
Facchiano A; Facchiano F; Facchiano A
FEBS Open Bio; 2020 Nov; 10(11):2363-2374. PubMed ID: 32970391
[TBL] [Abstract] [Full Text] [Related]
4. Co‑expression of peripheral olfactory receptors with SARS‑CoV‑2 infection mediators: Potential implications beyond loss of smell as a COVID‑19 symptom.
Kerslake R; Hall M; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
Int J Mol Med; 2020 Sep; 46(3):949-956. PubMed ID: 32705281
[TBL] [Abstract] [Full Text] [Related]
5. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Ziegler CGK; Allon SJ; Nyquist SK; Mbano IM; Miao VN; Tzouanas CN; Cao Y; Yousif AS; Bals J; Hauser BM; Feldman J; Muus C; Wadsworth MH; Kazer SW; Hughes TK; Doran B; Gatter GJ; Vukovic M; Taliaferro F; Mead BE; Guo Z; Wang JP; Gras D; Plaisant M; Ansari M; Angelidis I; Adler H; Sucre JMS; Taylor CJ; Lin B; Waghray A; Mitsialis V; Dwyer DF; Buchheit KM; Boyce JA; Barrett NA; Laidlaw TM; Carroll SL; Colonna L; Tkachev V; Peterson CW; Yu A; Zheng HB; Gideon HP; Winchell CG; Lin PL; Bingle CD; Snapper SB; Kropski JA; Theis FJ; Schiller HB; Zaragosi LE; Barbry P; Leslie A; Kiem HP; Flynn JL; Fortune SM; Berger B; Finberg RW; Kean LS; Garber M; Schmidt AG; Lingwood D; Shalek AK; Ordovas-Montanes J; ;
Cell; 2020 May; 181(5):1016-1035.e19. PubMed ID: 32413319
[TBL] [Abstract] [Full Text] [Related]
6. Vocal palsy increases the risk of lower respiratory tract infection in low-risk, low-morbidity patients undergoing thyroidectomy for benign disease: A big data analysis.
Nouraei SAR; Allen J; Kaddour H; Middleton SE; Aylin P; Darzi A; Tolley NS
Clin Otolaryngol; 2017 Dec; 42(6):1259-1266. PubMed ID: 28616866
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear C-MYC expression level is associated with disease progression and potentially predictive of two year overall survival in prostate cancer.
Zeng W; Sun H; Meng F; Liu Z; Xiong J; Zhou S; Li F; Hu J; Hu Z; Liu Z
Int J Clin Exp Pathol; 2015; 8(2):1878-88. PubMed ID: 25973080
[TBL] [Abstract] [Full Text] [Related]
8. Morphologic features of carcinomas with recurrent gene fusions.
Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
[TBL] [Abstract] [Full Text] [Related]
9. High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.
Minner S; Luebke AM; Kluth M; Bokemeyer C; Jänicke F; Izbicki J; Schlomm T; Sauter G; Wilczak W
Histopathology; 2012 Sep; 61(3):445-53. PubMed ID: 22463702
[TBL] [Abstract] [Full Text] [Related]
10. [tmprss2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens].
Xiao L; Zhu XZ; Wang Y; Gong Y; Guo CC
Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):392-6. PubMed ID: 21914348
[TBL] [Abstract] [Full Text] [Related]
11. miR-221 Is down-regulated in tmprss2:ERG fusion-positive prostate cancer.
Gordanpour A; Stanimirovic A; Nam RK; Moreno CS; Sherman C; Sugar L; Seth A
Anticancer Res; 2011 Feb; 31(2):403-10. PubMed ID: 21378318
[TBL] [Abstract] [Full Text] [Related]
12. Recurrent fusion oncogenes in carcinomas.
Teixeira MR
Crit Rev Oncog; 2006 Dec; 12(3-4):257-71. PubMed ID: 17425505
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients.
Pötzi C; Moameni A; Karanikas G; Preitfellner J; Becherer A; Pirich C; Dudczak R
Clin Endocrinol (Oxf); 2006 Oct; 65(4):519-23. PubMed ID: 16984246
[TBL] [Abstract] [Full Text] [Related]
